User menu

Fluoride therapy of type I osteoporosis.

Bibliographic reference Devogelaer, Jean-Pierre ; Nagant de Deuxchaisnes, C. Fluoride therapy of type I osteoporosis.. In: Clinical rheumatology, Vol. 14 Suppl 3, p. 26-31 (1995)
Permanent URL http://hdl.handle.net/2078.1/26378
  1. Nagant de Deuxchaisnes, C., Devogelaer, J.P., Depresseux, G., Malghem, J., Maldague, B. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements. J Bone Min Res 1990, 5 (suppl. 1), S5-S26.
  2. Farley, J.R., Wergedal, J.E., Baylink, D.J. Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone forming cells. Science 1983, 227, 320–332.
  3. Burkhart, J.M., Jowsey, J. Effects of variation in calcium intake on the skeleton of fluoride-fed kittens. J Lab Clin Med 1968, 72, 943–950.
  4. Jowsey, J., Riggs, B.L., Kelly, P.J., Hoffman, D.L. Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med 1972, 53, 43–49.
  5. Baylink, D.J., Bernstein, D.S. The effects of fluoride therapy on metabolic bone disease. An histologic study. Clin Orthop, 1967, 55, 51–85.
  6. Briançon, D., Meunier, P.J. Treatment of osteoporosis with fluoride, calcium and vitamin D. Orthop Clin North Am 1981, 12, 629–648.
  7. Dambacher, M.A., Lauffenburger, T., Olah, A.J., Fischer, J.A., Haas, H.G. Effet à court terme du fluorure de sodium (NaF), de l'association fluorure de sodium-vit. D3, du 1–25 dihydrocholecalciferol (1–25(OH)2D3) et de l'hormone de croissance humaine dans l'ostéoporose. In: L'Ostéoporose, Eds.: Rasmussen, H., Eisinger, J., Paecht, A., Symposium International. Paris, Armour Montagu, 1980, 189–194.
  8. Riggs, B.L., Hodgson, S.F., Hoffman, D.L., Kelly, P.J., Johnson, K.A., Taves, D. Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence. JAMA 1980, 243, 446–449.
  9. Riggs, B.L., Seeman, E., Hodgson, S.F. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med 1982, 306, 446–450.
  10. Devogelaer, J.P., Nagant de Deuxchaisnes, C., Stein, F. Bioavailability of enteric-coated sodium fluoride tablets as affected by the administration of calcium supplements at different time intervals. J Bone Min Res 1990, 5 (suppl. 1), S75-S79.
  11. Setnikar, I., Maurer, H. Bioequivalence of sodium monofluorophosphate with sodium fluoride and compatibility with calcium. Arzneimittelforsch 1990, 40 (II), 994–999.
  12. Müller P., Simon B., Schmid K., Warnecke G., Setnikar I., Gastric effects of sodium fluoride: Comparison with sodium monofluorophosphate, 10.1016/0169-6009(92)91999-y
  13. Murray, T.M., Harrison, J.E., Bayley, T.A., Josse, R.G., Sturtridge, W.C., Chow, R., Budden, F., Laurier, L., Pritzker, K.P.H., Kandel, R. Vieth, R., Strauss, A., Goodwin, S. Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response. J Bone Min Res 1990, 5 (suppl. 1), S27-S35.
  14. Riggs, B.L., Hodgson, S.F., O'Fallon, W.M., Chao, E.Y.S., Wahner, H.W., Muhs, J.M., Cedel, S.L., Melton, L.J. III. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990, 322, 802–809.
  15. Jowsey, J., Riggs, B.L., Kelly, P.J., Hoffman, D.L. Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med 1972, 53, 43–49.
  16. Riggs, B.L., Seeman, E., Hodgson, S.F., Taves, D.R., O'Fallon, W.M. Effect of the fluoride/calcium regimes on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med 1982, 306, 446–450.
  17. Franke, J., Hauch, S. Fractures and stress-fractures during NaF therapy. In: Osteoporosis 1990, Eds.: Christiansen, C., Overgaard, K., Copenhagen, Osteopress ApS, 1990, 1479–1483.
  18. Ringe, J.D., Maurer, H.: Fracture incidence does not increase during long-term fluoride/calcium therapy of primary osteoporosis. In: Osteoporosis 1990, Eds.: Christiansen, C., Overgaard, K., Copenhagen, Osteopress ApS, 1990, 1341–1343.
  19. Nagant de Deuxchaisnes, C., Devogelaer, J.P., Stein, F. Fluoride treatment for osteoporosis. Lancet 1990, 2, 48–49.
  20. Nagant de Deuxchaisnes, C., Devogelaer, J.P., Stein, F. Comparison of the bioavailability of the NaF capsules used in the NIH-sponsored trials as compared to that of NaF enteric-coated tablets commercially available in Europe. J Bone Min Res 1990, 5 (suppl. 2), S251.
  21. Mamelle, N., Meunier, P.J., Netter, P. Fluoride and vertebral fractures. Lancet 1990, 336, 243.
  22. Grove, O., Halver, B. Relief of osteoporotic backache with fluoride, calcium and calciferol. A randomized clinical trial. Acta Med Scand 1981, 209, 469–471.
  23. Kleerekoper, M., Balens, R., Foldes, J. Shih, M.S., Rao, D., Parfitt, A.M. Histomorphometric changes in iliac bone induced by sodium fluoride (NaF) therapy depend on cumulative dose. J Bone Min Res 1990, 5 (suppl. 2), S140, no 267.
  24. Meunier, P.J., Briançon, D., Vignon, E., Arlot, M., Chahon, S. Effect of combined therapy with sodium fluoride-vitamin D-calcium on vertebral fracture risk and bone histology in osteoporosis. In: Osteoporosis: Recent Advances in Pathogenesis and Treatment, Eds.: DeLuca, H.F., Frost H.M., Jee, W.S.S., Johnston C.C. Jr., Parfitt, A.M., Baltimore, University Park Press, 1980, 449–456.
  25. Hansson, T., Roos, B. The effect of fluoride and calcium on spinal bone mineral content: a controlled prospective (3 years) study. Calcif Tissue Int 1987, 40, 315–317.
  26. Dambacher, M.A., Ittner, J., Ruegsegger, P. Long-term fluoride therapy of postmenopausal osteoporosis. Bone 1986, 7, 199–205.
  27. Gutteridge, D.H., Kent, G.N., Price, R.I., Devlin, R.D. Fluoride in osteoporosis-avoidance of femoral fractures. In: Osteoporosis 1987, Eds.: Christiansen, C., Johansen, J.S., Riis, B.J., Copenhagen, Osteopress Aps, 1987, 871–875.
  28. Schnitzler, C.M., Wing, J.R., Mesquita, J.M., Gear, A.K., Robson, H.J., Smyth, A.E. Risk factors for the development of stress fractures during fluoride therapy for osteoporosis. J. Bone Min Res 1990, 5 (suppl. 1), S195-S200.
  29. Riggs B., O'Fallon W., Hodgson S., Chao E., Wahner H., Muhs J., Melton L., Clinical trial of fluoride in osteoporotic women: Extended observation and additional analyses, 10.1016/0169-6009(92)91660-b
  30. Mamelle, N., Meunier, P.J., Dusan, R., Guillaume, M., Martin, J.L., Gaucher, A., Prost, A., Zeigler, G., Netter, P. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet 1988, 2, 361–365.
  31. Heaney Robert P., Fluoride Therapy for the Vertebral Crush Fracture Syndrome : A Status Report, 10.7326/0003-4819-111-8-678
  32. Delmas, P.D., Dupuis, J., Duboeuf, F., Chapuy, M.C., Meunier, P.J. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J Bone Min Res 1990, 5 (suppl. 1), S143-S147.
  33. Liote, F., Bardin, C., Liou, A., Brouard, A., Terrier, J.L., Kuntz, D. Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate. Calcif Tissue Int 1992, 50, 209–213.
  34. Akhter, M.P., Turner, C.H. Fluoride intake versus bone strength in rat bones. J Bone Min Res 1990, 5 (suppl. 1), S98.
  35. Reeve, J., Davies, U.M., Hesp, R., McNally, E., Katz, D. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. Br Med J 1990, 301, 314–318 and 477.
  36. Vesterby, A., Gundersen, H.J.G., Melsen, F., Mosekilde, L. Marrow space star volume in the iliac crest decreases in osteoporotic patients after continuous treatment with fluoride, calcium, and vitamin D2 for five years. Bone 1991, 12, 33–37.
  37. Buckle, A.M. 3 year study of sodium fluoride treatment on vertebral fracture incidence in osteoporosis. J Bone Min Res 1989, 4 (suppl. 1), S186.
  38. Power, G.R.I., Gay, J.D.L. Sodium fluoride in the treatment of osteoporosis. Clin Invest Med 1986, 9, 41–43.
  39. Pak, C.Y.C., Sakhaee, K., Zerwekh, J.E., Parcel, C., Peterson, R., Johnson, K. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab 1989, 68, 150–159.
  40. Bayley, T.A., Muller, C., Harrison, J., Basuawo, J., Sturtbridge, W., Josse, R., Murray, T.M., Pritzker, K.P.H., Vieth, R., Goodwin, S., Strauss, A. The long-term treatment of steroid osteoporosis with fluoride. J Bone Min Res 1990, 5 (suppl. 1), S157-S161.
  41. Silverman, S., Greenwald, M., Brandli, D. Changes in health related quality of life during osteoporosis treatment. J Bone Min Res 1992, 7 (suppl. 1), S177 (abstract no 339).
  42. Stellon, A.J., Webb, A., Compston, J.E. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut 1988, 29, 378–384.
  43. Aaron, J.E., Francis, R.M., Peacock, M., Makins, N.B. Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Orthop 1989, 243, 294–305.
  44. Lender, M., Perelman, A., Eilon, G., Menczel, J. Treatment of osteogenesis imperfecta with sodium fluoride. Harefuah 1975, 88, 53–54.
  45. Schnitzler, C.M., Solomon, L. Trabecular stress fracture during fluoride therapy for osteoporosis. Skeletal Radiol 1985, 14, 276–279.
  46. Inkovaara, J., Heikinheimo, R., Jarvinen, K., Kasurinen, U., Hanhaijarvi, H., Iisalo, E. Prophylactic fluoride treatment and aged bones. Br Med J 1975, 2, 73–74.
  47. Gerster, J.C., Charhon, S.A., Jaeger, P., Boivin, G., Briançon, D., Rostan, A., Baud, C.A., Meunier, P.J. Bilateral fractures of femoral neck in patients with moderate renal failure receiving fluoride for spinal osteoporosis. Br Med J 1983, 287, 723.
  48. Vose G. P., Keele D. K., Milner A. M., Rawley R., Roach T. L., Sprinkle E. E., Effect of Sodium Fluoride, Inorganic Phosphate, and Oxymetholone Therapies in Osteoporosis: A Six-Year Progress Report, 10.1093/geronj/33.2.204
  49. Bailey, T.A., Harrison, J.E., Murray, T.M., Josse, R.G., Sturtridge, W., Pritzker, K.P.H., Strauss, A., Vieth, R., Goodwin, S. Fluorideinduced fraçtures: relation to osteogenic effect. J Bone Min Res 1990, 5 (suppl. 1), S217-S222.
  50. Hedlund, L.R., Gallagher, J.C. Increase incidence of hip fracture in osteoporotic women treated with sodium fluoride. J Bone Min Res 1989, 4, 223–225.
  51. Riggs, B.L., Baylink, D.J., Kleerekoper, M., Lane, J.M., Melton, L.J. III, Meunier, P.J. Incidence of hip fractures in osteoporotic women terated with sodium fluoride. J Bone Min Res 1987, 2, 123–126.
  52. Kanis, J.A., Johnell, O., Gullberg, B., Allander, E., Dilsen, G., Gennari, C., Lopes Vaz, A.A., Lyritis, G.P., Mazzuoli, G., Miravet, L., Passeri, M., Perez Cano, R., Rapado, A., Ribot, C. Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. Br Med J 1992, 305, 1124–1128.
  53. Jensen, G.F., Christiansen, C., Boesen, J., Hegedüs, V., Transbol, I. Epidemiology of postmenopausal spinal and long bone fractures. Clin Orthop 1982, 166, 75–81.
  54. Duursman, S.A., Raymakers, J.A., De Raadt, M.E., Karsdorp, N.J.G.H., Van Dijk, A., Glerum, J. Urinary fluoride excretion in responders and nonresponders after fluoride therapy in osteoporosis. J Bone Min Res 1990, 5 (suppl. 1), S43-S47.
  55. Marcelli, C., Arlot, M., Boivin, G., Chapuy, P.C., Meunier, P.J. Comparison between responders osteoporotic women treated 2 years with sodium fluoride-Ca-vitamin D. A histomorphometric and biochemical survey. In: Calcium Regulation and Bone Metabolism. Basic and Clinical Aspects, Eds.: Cohn, D.V., Martin, T.J., Meunier, P.J., Amsterdam, Excerpta Medica, 1987, 9, 859.
  56. Talbot, J.R., Fischer, M.M., Farley, S.M., Dure-Smith, B., Schultz, E., Libanati, C., Baylink, D.J. Gains made in spinal bone density (SBD) in response to fluoride (F) therapy for osteoporosis are not maintained after F therapy is discontinued. J Bone Min Res 1992, 7 (suppl. 1), S118 (abstract no 101).
  57. Van Linthoudt, D., Baud, C.A., Courvoisier, B., Ott, H. Longterm follow up of osteoporotic patients after sodium fluoride treatment interruption. In: Osteoporosis 1987, Eds: Christiansen, C., Johansen, J.S., Riis, B.J., Copenhagen, Osteopress Aps, 1987, 860–862.